The Asia Pacific cancer vaccines market was valued at US$ 861.55 million in 2019 and is projected to reach US$ 3,131.09 million by 2027; it is expected to grow at a CAGR of 17.9% during the forecast period.
The growth of the Asia Pacific Cancer Vaccines market is mainly attributed to the growing prevalence of cancer and initiatives taken by global health organization.In Asia Pacific, China is the largest market for cancer vaccines market. The growth of the market is primarily attributed to the growing biotechnology market, increasing developments by the market players, and favorable regulatory policies. The excessive population in China coupled with the rise of cancer prevalence is majorly driving the growth of the cancer vaccines in China and making it a prime market in the Asia Pacific region.
In addition, in the last few years, the companies in china are undergoing collaborations, partnerships and mergers to advance the cancer vaccines technology. For instance, Researchers from Queen Mary University of London and Zhengzhou University collaborated to develop a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. The research was funded by the Chinese Ministry of Science and Technology and Zhengzhou University and was published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
China Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)
ASIA PACIFIC CANCER VACCINES – MARKET SEGMENTATION
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End Use
- Pediatrics
- Adults
By Country
- US
- Canada
- Mexico
Company Profiles
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Type, Indication, End User, and Country and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction. 17
1.1 Scope of the Study. 17
1.2 The Insight Partners Research Report Guidance. 17
1.3 Market Segmentation. 19
1.3.1 Asia Pacific Cancer Vaccines Market – By Technology. 21
1.3.2 Asia Pacific Cancer Vaccines Market – By Type. 21
1.3.3 Asia Pacific Cancer Vaccines Market – By Indication. 21
1.3.4 Asia Pacific Cancer Vaccines Market– By End Use. 21
1.3.5 Asia Pacific Cancer Vaccines Market– By Region. 22
2. Cancer Vaccines Market – Key Takeaways. 23
3. Research Methodology. 27
3.1 Coverage. 29
3.2 Secondary Research. 29
3.3 Primary Research. 30
4. Cancer Vaccines – Market Landscape. 31
4.1 Overview.. 31
4.2 PEST Analysis. 31
4.3 Expert Opinion. 32
5. Asia Pacific Cancer Vaccines Market – Industry Dynamics. 33
5.1 Key Drivers. 33
5.1.1 Increase in Prevalence of Cancer Worldwide. 33
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines. 34
5.2 Key Market Restraints. 35
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer 35
5.2.2 Higher Cost of Cancer Vaccines. 35
5.3 Key Market Opportunities. 36
5.3.1 Emerging Markets in Developing Countries. 36
5.4 Future Trends. 36
5.4.1 Growing Research and Development Activities. 36
5.5 Impact analysis. 38
6. Cancer Vaccines Market – Regional Analysis. 39
6.1 Asia Pacific Cancer Vaccines Market Revenue Forecast And Analysis. 39
7. Asia Pacific Cancer Vaccines Market Analysis – By Technology. 40
7.1 Overview.. 40
7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%) 40
7.3 Dendritic Cells Cancer Vaccine. 42
7.3.1 Overview.. 42
7.3.2 Dendritic Cells Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 43
7.5 Recombinant Cancer Vaccines. 44
7.5.1 Overview.. 44
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 45
7.6 Antigen Cancer Vaccines. 46
7.6.1 Overview.. 46
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 47
7.7 Whole Cell Cancer Vaccines. 48
7.7.1 Overview.. 48
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 49
7.8 Viral Vector Cancer Vaccines. 50
7.8.1 Overview.. 50
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 51
8. Cancer Vaccines Market Analysis – By Type. 52
8.1 Overview.. 52
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027) 52
8.3 Preventive Cancer Vaccines. 54
8.3.1 Overview.. 54
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 55
8.4 Therapeutic Cancer Vaccines. 56
8.4.1 Overview.. 56
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 57
9. Cancer Vaccines Market Analysis – By Indication. 58
9.1 Overview.. 58
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027) 58
9.3 Cervical Cancer 60
9.3.1 Overview.. 60
9.3.2 Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 61
9.4 Prostate Cancer 62
9.4.1 Overview.. 62
9.4.2 Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 63
9.5 Other Indications. 64
9.5.1 Overview.. 64
9.5.2 Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 65
10. Cancer Vaccines Market Analysis – By End Use. 66
10.1 Overview.. 66
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027) 66
10.3 Pediatrics. 67
10.3.1 Overview.. 67
10.3.2 Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 68
10.4 Adults. 69
10.4.1 Overview.. 69
10.4.2 Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 70
11. Cancer Vaccines Market – Geographic Analysis. 71
11.1 Asia Pacific: Cancer Vaccines Market 71
11.1.1 Overview.. 71
11.1.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million) 72
11.1.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 73
11.1.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 74
11.1.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 74
11.1.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 75
11.1.7 Asia Pacific: Cancer Vaccines Market, by Country, 2019 & 2027 (%) 75
11.1.8 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 76
11.1.8.1 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 77
11.1.8.2 China: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 78
11.1.8.3 China: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 78
11.1.8.4 China: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 79
11.1.8.5 China: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 80
11.1.9 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 81
11.1.9.1 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 82
11.1.9.2 Japan: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 83
11.1.9.3 Japan: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 83
11.1.9.4 Japan: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 84
11.1.9.5 Japan: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 85
11.1.10 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 86
11.1.10.1 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 87
11.1.10.2 India: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 88
11.1.10.3 India: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 89
11.1.10.4 India: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 89
11.1.10.5 India: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 91
11.1.11 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 92
11.1.11.1 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 93
11.1.11.2 South Korea: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 94
11.1.11.3 South Korea: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 94
11.1.11.4 South Korea: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 95
11.1.11.5 South Korea: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 96
11.1.12 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 97
11.1.12.1 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 98
11.1.12.2 Australia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 99
11.1.12.3 Australia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 99
11.1.12.4 Australia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 100
11.1.12.5 Australia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 101
12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market 102
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic. 102
13. Cancer Vaccines Market – Industry Landscape. 104
13.1 Overview.. 104
13.2 Growth Strategies Done by the Companies in the Market, (%) 105
13.3 Organic Developments. 106
13.3.1 Overview.. 106
13.4 Inorganic Developments. 107
13.4.1 Overview.. 107
14. Company Profiles. 109
14.1 CSL Limited. 109
14.1.1 Key Facts. 109
14.1.2 Business Description. 109
14.1.3 Products and Services. 110
14.1.4 Financial Overview.. 111
14.1.5 SWOT Analysis. 113
14.1.6 Key Developments. 114
14.2 ADURO BIOTECH INC. 115
14.2.1 Key Facts. 115
14.2.2 Business Description. 115
14.2.3 Products and Services. 116
14.2.4 Financial Overview.. 117
14.2.5 SWOT Analysis. 118
14.2.6 Key Developments. 119
14.3 Astellas Pharma Inc. 120
14.3.1 Key Facts. 120
14.3.2 Business Description. 120
14.3.3 Products and Services. 121
14.3.4 Financial Overview.. 122
14.3.5 SWOT Analysis. 124
14.3.6 Key Developments. 125
14.4 Bristol-Myers Squibb Company. 126
14.4.1 Key Facts. 126
14.4.2 Business Description. 126
14.4.3 Products and Services. 127
14.4.4 Financial Overview.. 128
14.4.5 SWOT Analysis. 131
14.4.6 Key Developments. 132
14.5 GlaxoSmithKline plc. 133
14.5.1 Key Facts. 133
14.5.2 Business Description. 133
14.5.3 Products and Services. 134
14.5.4 Financial Overview.. 135
14.5.5 SWOT Analysis. 139
14.5.6 Key Developments. 140
14.6 Dendreon. 141
14.6.1 Key Facts. 141
14.6.2 Business Description. 141
14.6.3 Products and Services. 141
14.6.4 Financial Overview.. 141
14.6.5 SWOT Analysis. 142
14.6.6 Key Developments. 143
14.7 AstraZeneca. 144
14.7.1 Key Facts. 144
14.7.2 Business Description. 144
14.7.3 Products and Services. 145
14.7.4 Financial Overview.. 146
14.7.5 SWOT Analysis. 148
14.7.6 Key Developments. 149
14.8 Merck & Co., Inc. 150
14.8.1 Key Facts. 150
14.8.2 Business Description. 150
14.8.3 Products and Services. 151
14.8.4 Financial Overview.. 152
14.8.5 SWOT Analysis. 156
14.8.6 Key Developments. 156
14.9 Sanofi (Sanofi Pasteur) 158
14.9.1 Key Facts. 158
14.9.2 Business Description. 158
14.9.3 Products and Services. 159
14.9.4 Financial Overview.. 160
14.9.5 SWOT Analysis. 164
14.9.6 Key Developments. 164
14.10 OSE Immunotherapeutics. 166
14.10.1 Key Facts. 166
14.10.2 Business Description. 166
14.10.3 Products and Services. 167
14.10.4 Financial Overview.. 168
14.10.5 SWOT Analysis. 170
14.10.6 Key Developments. 170
15. Appendix. 172
15.1 Glossary of Terms
. 172
LIST OF TABLES
Table 1. Asia Pacific Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million) 73
Table 2. Asia Pacific Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 74
Table 3. Asia Pacific Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 74
Table 4. Asia Pacific Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 75
Table 5. China Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 78
Table 6. China Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 78
Table 7. China Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 79
Table 8. China Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 80
Table 9. Japan Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 83
Table 10. Japan Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 83
Table 11. Japan Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 84
Table 12. Japan Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 85
Table 13. India Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 88
Table 14. India Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 89
Table 15. India Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 89
Table 16. India Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 91
Table 17. South Korea Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 94
Table 18. South Korea Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 94
Table 19. South Korea Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 95
Table 20. South Korea Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 96
Table 21. Incidence, Mortality and Prevalence by cancer site, Australia, 2018. 97
Table 22. Australia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 99
Table 23. Australia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 99
Table 24. Australia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 100
Table 25. Australia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 101
Table 26. Organic Developments Done By Companies. 106
Table 27. Inorganic Developments Done By Companies. 107
Table 28. Glossary of Terms, Cancer Vaccines Market
172
LIST OF FIGURES
Figure 1. Cancer Vaccines Market Segmentation. 19
Figure 2. Cancer Vaccines Segmentation – By Region. 20
Figure 3. Asia Pacific Cancer Vaccines Market Overview.. 23
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019. 24
Figure 5. Cancer Vaccines Market in Japan to Show Remarkable Growth During Forecast Period. 25
Figure 7. Asia Pacific PEST Analysis. 31
Figure 8. Cancer Statistics, 2020. 33
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints. 38
Figure 10. Asia Pacific Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027. 39
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%) 40
Figure 12. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 43
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 45
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 47
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 49
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 51
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027) 52
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 55
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 57
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027) 58
Figure 21. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 61
Figure 22. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 63
Figure 23. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 65
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027) 66
Figure 25. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 68
Figure 26. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 70
Figure 27. Asia Pacific: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million) 71
Figure 28. Asia Pacific Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million) 72
Figure 29. China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 77
Figure 30. Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 82
Figure 31. India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 87
Figure 32. South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 93
Figure 33. Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 98
Figure 34. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets. 103
Figure 35. Growth Strategies Done by the Companies in the Market, (%) 105
The List of Companies - Asia Pacific Cancer Vaccines Market
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Cancer Vaccines Market
Oct 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)